Hualan Biological EngineeringInc Cash Flow Reinvestment Rate
Hualan Biological EngineeringInc cash flow reinvestment rate. Hualan Biological EngineeringInc (002007) has a Cash Flow Reinvestment Rate of 0.11x as of September 2025, reinvesting CN¥36.14 Million (capex CN¥36.14 Million ) from operating cash flow of CN¥319.46 Million. Explore Hualan Biological EngineeringInc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Hualan Biological EngineeringInc (2003–2024)
Cash flow reinvestment rate of Hualan Biological EngineeringInc from 2003 to 2024. Historical reinvestment intensity for Hualan Biological EngineeringInc across 22 annual periods. Explore 002007 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Hualan Biological EngineeringInc Cash Flow Reinvestment Rate by Year (2003–2024)
Hualan Biological EngineeringInc cash flow reinvestment rate by year from 2003 to 2024. Year-by-year capital reinvestment analysis for Hualan Biological EngineeringInc. For the full cash flow conversion analysis, see how efficiently does Hualan Biological EngineeringInc generate cash.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.57x | CN¥599.21 Million | CN¥1.06 Billion | CN¥255.79 Million | ▼ -56.5% |
| 2023 | 1.30x | CN¥1.75 Billion | CN¥1.35 Billion | CN¥753.41 Million | ▼ -51.5% |
| 2022 | 2.68x | CN¥2.57 Billion | CN¥957.31 Million | CN¥393.95 Million | ▲ +103.8% |
| 2021 | 1.32x | CN¥1.89 Billion | CN¥1.43 Billion | CN¥811.35 Million | ▲ +106.5% |
| 2020 | 0.64x | CN¥845.31 Million | CN¥1.33 Billion | CN¥621.44 Million | ▲ +2.9% |
| 2019 | 0.62x | CN¥845.09 Million | CN¥1.36 Billion | CN¥272.95 Million | ▼ -14.4% |
| 2018 | 0.72x | CN¥936.97 Million | CN¥1.29 Billion | CN¥183.26 Million | ▲ +3.6% |
| 2017 | 0.70x | CN¥124.12 Million | CN¥177.42 Million | CN¥108.54 Million | ▼ -3.8% |
| 2016 | 0.73x | CN¥239.94 Million | CN¥329.94 Million | CN¥220.66 Million | ▼ -29.9% |
| 2015 | 1.04x | CN¥569.20 Million | CN¥548.62 Million | CN¥229.34 Million | ▲ +270.5% |
| 2014 | 0.28x | CN¥139.21 Million | CN¥497.15 Million | CN¥139.21 Million | ▼ -42.6% |
| 2013 | 0.49x | CN¥249.21 Million | CN¥510.70 Million | CN¥249.21 Million | ▲ +64.0% |
| 2012 | 0.30x | CN¥147.15 Million | CN¥494.69 Million | CN¥147.15 Million | ▼ -30.4% |
| 2011 | 0.43x | CN¥143.59 Million | CN¥335.93 Million | CN¥143.59 Million | ▲ +74.1% |
| 2010 | 0.25x | CN¥149.67 Million | CN¥609.53 Million | CN¥149.67 Million | ▼ -8.1% |
| 2009 | 0.27x | CN¥162.43 Million | CN¥607.73 Million | CN¥162.43 Million | ▼ -66.1% |
| 2008 | 0.79x | CN¥126.90 Million | CN¥161.18 Million | CN¥126.90 Million | ▼ -34.1% |
| 2007 | 1.19x | CN¥213.92 Million | CN¥179.02 Million | CN¥213.92 Million | ▼ -27.7% |
| 2006 | 1.65x | CN¥217.30 Million | CN¥131.43 Million | CN¥217.30 Million | ▲ +177.2% |
| 2005 | 0.60x | CN¥58.59 Million | CN¥98.24 Million | CN¥58.59 Million | ▼ -41.8% |
| 2004 | 1.02x | CN¥22.00 Million | CN¥21.48 Million | CN¥22.00 Million | ▼ -89.6% |
| 2003 | 9.81x | CN¥32.82 Million | CN¥3.35 Million | CN¥32.82 Million | — |